DNA Sequencing

DNA Sequencing Market Reaches U$$ 40.64 Billion Mark By 2030 DNA Sequencing Market (By Product: Instruments, Consumables, and Services; By Technology: Third Generation DNA Sequencing, Next-Generation Sequencing, and Sanger Sequencing; By Application: Clinical Investigation, Oncology, Forensics & Agrigenomics, Reproductive Health, HLA Typing, and Others; By End-Use: Clinical Research, Academic Research, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, and Others) - Global Market Size, Share, Trends Analysis, Segment Forecast, Regional Outlook 2021 - 2030

Share This Article

The DNA sequencing market is expected to exhibit a CAGR of 17.5% from 2021 to 2030 and is projected to reach US$ 40.64 Billion by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global DNA sequencing market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global DNA sequencing market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the DNA sequencing industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1189

DNA sequencing is a procedure used to ascertain the nucleotide sequence of DNA (deoxyribonucleic acid). The nucleotide sequence is a blueprint that encompasses the directives for building an organism, and no perception of the genetic function or progression can be complete without gaining this data. The nucleotide sequence is thus an essential level of information of a genome or gene. Sequencing a complete genome is a complex task that requires separating the DNA of the genome into numerous smaller fragments, sequencing the fragments, and gathering the sequences into a sole long consensus.

The early methods of sequencing (also known as first-generation sequencing technologies) were developed in the 1970s which included Maxam-Gilbert and Sanger method. However, next-generation sequencing methods have mostly supplanted the first-generation methods. These newer methods enable numerous DNA fragments (occasionally on the order of millions of strands) to be sequenced at one time and are more cost-effective and much quicker than first-generation methods. The efficacy of next-generation methods was enhanced significantly by advances in the field of bioinformatics that allowed for augmented data storage and helped the analysis and handling of very big data sets.

What are the market growth factors?

Factors such as constant technological advancements in the sequencing methods, developments in the field of bioinformatics, increasing applications of NGS (Next-generation Sequencing) and WGS (Whole-genome Sequencing), growing prevalence of viral diseases such as SARS and COVID-19, increasing cases of cancer globally, and growing research and development expenditure are propelling the DNA sequencing market expansion across the globe. Additional aspects that are anticipated to fuel this industry are applications in cancer research, biomarker discovery, personalized medicine, genomic analysis, and forensics. Constant collaborations and partnerships between major market players in order to launch new and innovative technologies have enhanced the demand for overall market for the DNA sequencing market.

DNA sequencing also has applications in the field of animal and plant breeding. Selecting the finest animals for next generation breeding is needs an in-depth understanding of the livestock genetics. Genomics technologies are entirely established in breeding and are becoming further competent due to technology innovations and progresses. The area of modern farming has instituted techniques such as genome sequencing, genome wide association, genotyping, and genetic markers. Moreover, genome sequencing has reached satisfactory success in beef cattle and milk cow breeding with enhanced properties in characters such as milk yield, beef quality, feed efficiency, and health.

Report Scope of the DNA Sequencing Market

Report Highlights Details
Market Size US$ 40.64 billion by 2030
Growth Rate CAGR of 17.5% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, technology, Application, End Use
Companies Mentioned Agilent Technologies, Illumina, Inc., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Hoffmann-La Roche Ltd., Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetics

Report Highlights:

  • Among the product segment, consumables are expected to dominate the overall market. High requirement for consumables such as reagents and kits for DNA fragmentation and amplification is the major reason for high market share of consumables.
  • The next-generation sequencing accounted for the largest revenue in the technology segment with more than 52% share in 2020. Factors such as tremendous advances in NGS technologies along with reduction in cost drive the growth if next-generation sequencing technologies.
  • Oncology accounted for the largest revenue in the application segment. High prevalence of cancer in developing regions is the key reason for high market share of oncology.
  • Academic research centers accounted for the largest revenue in the end-use segment. High investment in research and development is the key reason for high market share of academic research centers.
  • Illumina, Inc. accounted for a significant share of the global DNA sequencing market.

Regional Analysis:

The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 42%. U.S. represented the highest share in the North American region primarily due to presence of leading market players and high awareness regarding next-generation sequencing technologies. Furthermore, early adoption of latest sequencing technologies also contributed to the high market share of the United States.

Europe was the second important market chiefly due to high investment in research and development and presence of skilled researchers. High incidence of cancer in the European region is also expected to boost the demand for DNA Sequencing market in the near future. Asia Pacific is anticipated to grow at the maximum CAGR of around14% in the forecast period due to high incidence of viral disorders. Latin America and the African and Middle Eastern region will display noticeable growth.

Related Reports

  • Generic Drugs Market – The global market size is predicted to hit around USD 675.29 billion by 2030, representing impressive CAGR of 5.7% over forecast period 2021 to 2030. The global generic drugs market size was valued at USD 387.92 billion in 2020. 
  • Genomics Market – The global market size is projected to hit over USD 72.13 billion by 2030 and is expanding at a CAGR of 13.65% during the forecast period 2021 to 2030. The global genomics market size was valued at USD 20.06 billion in 2020. 
  • Smart Healthcare Products Market – The global market size is expected to be worth around USD 85.37 billion by 2030 with a CAGR of 9.2% over forecast period 2021 to 2030. The global smart healthcare products market size was estimated at USD 44.65 billion in 2020.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global DNA sequencing market are as follows:

  • Agilent Technologies
  • Illumina, Inc.
  • QIAGEN
  • Perkin Elmer
  • Thermo Fisher Scientific
  • Hoffmann-La Roche Ltd.
  • Macrogen, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Myriad Genetics

Market Segmentation

By Product

  • Instruments
  • Consumables
  • Services

By Technology

  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing

By Application

  • Clinical Investigation
  • Oncology
  • Forensics & Agrigenomics
  • Reproductive Health
  • HLA Typing
  • Others

By End-Use

  • Clinical Research
  • Academic Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global DNA sequencing market. It examines trends and factors influencing demand for DNA sequencing globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for DNA sequencing across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on DNA sequencing. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global DNA sequencing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for DNA sequencing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. DNA Sequencing Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on DNA Sequencing Market

5.1. Covid-19: DNA Sequencing Industry Impact
5.2. DNA Sequencing Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and DNA Sequencing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for DNA Sequencing Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. DNA Sequencing Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Technological advances in next-generation sequencing technologies
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rising demand for precision medicine
6.1.3.2. Technological advancements

Chapter 7. Global DNA Sequencing Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. DNA Sequencing Market Revenue by Market Players (2016 -2019)
7.1.1.2. DNA Sequencing Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product, 2017 – 2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017 – 2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017 – 2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017 – 2030)

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology, 2017 – 2030
9.1.1. Third Generation DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2017 – 2030)
9.1.2. Next-Generation Sequencing
9.1.2.1. Market Revenue and Forecast (2017 – 2030)
9.1.3. Next-Generation Sequencing
9.1.3.1. Market Revenue and Forecast (2017 – 2030)

Chapter 10. Global DNA Sequencing Market, By Application

10.1. DNA Sequencing Market, by Application, 2017 – 2030
10.1.1. Clinical Investigation
10.1.1.1. Market Revenue and Forecast (2017 – 2030)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2017 – 2030)
10.1.3. Forensics & Agrigenomics
10.1.3.1. Market Revenue and Forecast (2017 – 2030)
10.1.4. Reproductive Health
10.1.4.1. Market Revenue and Forecast (2017 – 2030)
10.1.5. HLA Typing
10.1.5.1. Market Revenue and Forecast (2017 – 2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017 – 2030)

Chapter 11. Global DNA Sequencing Market, By End Use

11.1. DNA Sequencing Market, by End-Use, 2017 – 2030
11.1.1. Clinical Research
11.1.1.1. Market Revenue and Forecast (2017 – 2030)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2017 – 2030)
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2017 – 2030)
11.1.4. Hospitals & Clinics
11.1.4.1. Market Revenue and Forecast (2017 – 2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017 – 2030)

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2017 – 2030)
12.1.2. Market Revenue Forecast by Technology(2017 – 2030)
12.1.3. Market Revenue Forecast by Application (2017 – 2030)
12.1.4. Market Revenue Forecast by End-Use (2017 – 2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017 – 2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017 – 2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017 – 2030)
12.2.2. Market Revenue Forecast by Technology (2017 – 2030)
12.2.3. Market Revenue Forecast by Application (2017 – 2030)
12.2.4. Market Revenue Forecast by End-Use (2017 – 2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017 – 2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017 – 2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017 – 2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017 – 2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017 – 2030)
12.3.2. Market Revenue Forecast by Technology (2017 – 2030)
12.3.3. Market Revenue Forecast by Application (2017 – 2030)
12.3.4. Market Revenue Forecast by End-Use (2017 – 2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017 – 2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017 – 2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017 – 2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017 – 2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017 – 2030)
12.4.2. Market Revenue Forecast by Technology (2017 – 2030)
12.4.3. Market Revenue Forecast by Application (2017 – 2030)
12.4.4. Market Revenue Forecast by End-Use (2017 – 2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017 – 2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017 – 2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017 – 2030)
12.5.2. Market Revenue Forecast by Technology (2017 – 2030)
12.5.3. Market Revenue Forecast by Application (2017 – 2030)
12.5.4. Market Revenue Forecast by End-Use (2017 – 2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017 – 2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017 – 2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017 – 2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017 – 2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.1.4. Recent Developments and Strategies
13.2. Illumina, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.2.4. Recent Developments and Strategies
13.3. QIAGEN
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.3.4. Recent Developments and Strategies
13.4. Perkin Elmer
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.4.4. Recent Developments and Strategies
13.5. Thermo Fisher Scientific
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.5.4. Recent Developments and Strategies
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.6.4. Recent Developments and Strategies
13.7. Macrogen, Inc.
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.7.4. Recent Developments and Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.8.4. Recent Developments and Strategies
13.9. Oxford Nanopore Technologies Ltd.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.9.4. Recent Developments and Strategies
13.10. Myriad Genetics
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017 – 2020)
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1189

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →